TABLE 1.
# | Searches |
---|---|
1 | Middle east respiratory syndrome coronavirus [mesh] |
2 | Severe acute respiratory syndrome [mesh] |
3 | SARS virus [mesh] |
4 | Betacoronavirus [mesh] |
5 | COVID‐19 [word text] |
6 | or/1–5 |
7 | Immunosuppressive agents [pharmacological action] |
8 | Immunosuppression [mesh] |
9 | Psoriasis [word text] |
10 | Psoriatic arthritis [word text] |
11 | Transplants/therapy [mesh] |
12 | Transplants/transplantation [mesh] |
13 | biologic [word text] |
14 | Infliximab/therapeutic use [mesh] |
15 | Adalimumab/therapeutic use [mesh] |
16 | Steroids/drug therapy [mesh] OR |
17 | Steroids/pharmacology [mesh] |
18 | Steroids/therapeutic use [mesh] |
19 | Ustekinumab [mesh] |
20 | guselkumab [supplementary concept] |
21 | risankizumab [supplementary concept] |
22 | anti‐IL 23 [word text] |
23 | Ixekizumab [supplementary concept] |
24 | Secukinumab [supplementary concept] |
25 | Brodalumab [supplementary concept] |
26 | Bimekizumab [supplementary concept] |
27 | or/7‐26 |
28 | animals/not humans/ |
29 | 27 not 28 |
30 | and/6,29 |
31 | limit 30 to (clinical conference or editorial) |
32 | 30 not 31 |
33 | remove duplicates from 32 |
Note: Database(s): NCBI PubMed Central (PMC) MEDLINE(R) U.S. National Institutes of Health's National Library Medicine; Embase Classic+Embase 1947 to May 14, 2020 Search Strategy run on May 14, 2020.